Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia

被引：29

作者：

Yoest, Jennifer M. ^{[1
]}

Shirai, Cara Lunn ^{[2
]}

Duncavage, Eric J. ^{[2
]}

机构：

[1] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA

[2] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA

来源：

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2020年 / 8卷

关键词：

measurable (minimal) residual disease; acute myeloid leukemia; next generation sequencing; unique molecular identifier; error-corrected sequencing; clinical applications of NGS; AML MRD; QUANTITATIVE RT-PCR; CLONAL HEMATOPOIESIS; TANDEM DUPLICATION; INDUCTION THERAPY; RARE MUTATIONS; DIGITAL PCR; RISK; AML; DIAGNOSIS; TRANSPLANTATION;

D O I：

10.3389/fcell.2020.00249

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Next generation sequencing (NGS) methods have allowed for unprecedented genomic characterization of acute myeloid leukemia (AML) over the last several years. Further advances in NGS-based methods including error correction using unique molecular identifiers (UMIs) have more recently enabled the use of NGS-based measurable residual disease (MRD) detection. This review focuses on the use of NGS-based MRD detection in AML, including basic methodologies and clinical applications.

引用

页数：10

共 72 条

[1] Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing [J].

Balagopal, Vidya ;

Hantel, Andrew ;

Kadri, Sabah ;

Steinhardt, George ;

Zhen, Chao Jie ;

Kang, Wenjun ;

Wanjari, Pankhuri ;

Ritterhouse, Lauren L. ;

Stock, Wendy ;

Segal, Jeremy P. .

PLOS ONE, 2019, 14 (10)

[2] Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia [J].

Bibault, Jean-Emmanuel ;

Figeac, Martin ;

Helevaut, Nathalie ;

Rodriguez, Celine ;

Quief, Sabine ;

Sebda, Sheherazade ;

Renneville, Aline ;

Nibourel, Olivier ;

Rousselot, Philippe ;

Gruson, Berengere ;

Dombret, Herve ;

Castaigne, Sylvie ;

Preudhomme, Claude .

ONCOTARGET, 2015, 6 (26) :22812-22821

[3] Time to repeal and replace response criteria for acute myeloid leukemia? [J].

Bloomfield, Clara Derber ;

Estey, Elihu ;

Pleyer, Lisa ;

Schuh, Andre C. ;

Stein, Eytan M. ;

Tallman, Martin S. ;

Wei, Andrew .

BLOOD REVIEWS, 2018, 32 (05) :416-425

[4] Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia [J].

Brunetti, Claudia ;

Anelli, Luisa ;

Zagaria, Antonella ;

Minervini, Angela ;

Minervini, Crescenzio F. ;

Casieri, Paola ;

Coccaro, Nicoletta ;

Cumbo, Cosimo ;

Tota, Giuseppina ;

Impera, Luciana ;

Orsini, Paola ;

Specchia, Giorgina ;

Albano, Francesco .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (03) :437-444

[5] Genomics of Acute Myeloid Leukemia Diagnosis and Pathways [J].

Bullinger, Lars ;

Doehner, Konstanze ;

Doehner, Hartmut .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) :934-946

[6] Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial [J].

Burnett, Alan K. ;

Russell, Nigel H. ;

Hills, Robert K. ;

Bowen, David ;

Kell, Jonathan ;

Knapper, Steve ;

Morgan, Yvonne G. ;

Lok, Jennie ;

Grech, Angela ;

Jones, Gail ;

Khwaja, Asim ;

Friis, Lone ;

McMullin, Mary Frances ;

Hunter, Ann ;

Clark, Richard E. ;

Grimwade, David .

LANCET ONCOLOGY, 2015, 16 (13) :1295-1305

[7] Genetic and epigenetic determinants of AML pathogenesis [J].

Cai, Sheng F. ;

Levine, Ross L. .

SEMINARS IN HEMATOLOGY, 2019, 56 (02) :84-89

[8] Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia [J].

Dillon, Laura W. ;

Hayati, Sheida ;

Roloff, Gregory W. ;

Tunc, Ilker ;

Pirooznia, Mehdi ;

Mitrofanova, Antonina ;

Hourigan, Christopher S. .

HAEMATOLOGICA, 2019, 104 (02) :297-304

[9] Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing [J].

Ding, Li ;

Ley, Timothy J. ;

Larson, David E. ;

Miller, Christopher A. ;

Koboldt, Daniel C. ;

Welch, John S. ;

Ritchey, Julie K. ;

Young, Margaret A. ;

Lamprecht, Tamara ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Wallis, John W. ;

Lu, Charles ;

Shen, Dong ;

Harris, Christopher C. ;

Dooling, David J. ;

Fulton, Robert S. ;

Fulton, Lucinda L. ;

Chen, Ken ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

Magrini, Vincent J. ;

Cook, Lisa ;

McGrath, Sean D. ;

Vickery, Tammi L. ;

Wendl, Michael C. ;

Heath, Sharon ;

Watson, Mark A. ;

Link, Daniel C. ;

Tomasson, Michael H. ;

Shannon, William D. ;

Payton, Jacqueline E. ;

Kulkarni, Shashikant ;

Westervelt, Peter ;

Walter, Matthew J. ;

Graubert, Timothy A. ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

DiPersio, John F. .

NATURE, 2012, 481 (7382) :506-510

[10] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

← 1 2 3 4 5 6 7 8 →